{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:12:15Z","timestamp":1792044735552,"version":"4.4.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/inf.0b013e3181fdff4a","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T02:55:01Z","timestamp":1287543301000},"page":"352-355","source":"Crossref","is-referenced-by-count":62,"title":["THE CLINICAL SPECTRUM OF PATIENTS WITH DEFICIENCY OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-1"],"prefix":"10.1097","volume":"30","author":[{"given":"Diana","family":"Averbuch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Chapgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Boisson-Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2007.10.005","article-title":"Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.","volume":"20","author":"Bustamante","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","article-title":"Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.","volume":"18","author":"Filipe-Santos","year":"2006","journal-title":"Semin Immunol"},{"key":"R3-20-20210202","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans.","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest"},{"key":"R4-20-20210202","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet"},{"key":"R5-20-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"R6-20-20210202","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo.","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency.","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"R8-20-20210202","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1086\/425021","article-title":"Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.","volume":"190","author":"MacLennan","year":"2004","journal-title":"J Infect Dis"},{"key":"R9-20-20210202","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1164\/ajrccm.163.supplement_1.2011109","article-title":"Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link.","volume":"163","author":"Sigurs","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2005.09.009","article-title":"Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction.","volume":"344","author":"Ramaswamy","year":"2006","journal-title":"Virology"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.168.6.2944","article-title":"The role of IFN in respiratory syncytial virus pathogenesis.","volume":"168","author":"Durbin","year":"2002","journal-title":"J Immunol"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/JVI.77.10.5933-5947.2003","article-title":"Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.","volume":"77","author":"Zhang","year":"2003","journal-title":"J Virol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201104000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:44:03Z","timestamp":1786041843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201104000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181fdff4a","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}